Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th
Back

California Recreational Cannabis Receives Endorsement

May 11, 2017 • 12:06 PM EDT
Cali.png
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

The California cannabis industry scored a victory last night as it received strong support from its Attorney General. We are thrilled by these comments as it should further the conversation with the Federal government and in turn, provide more clarity on the matter.

California Attorney General Xavier Becerra spoke out yesterday and said that he does not plan to let the new White House administration interfere with the state’s plan to legalize recreational marijuana. This program is expected to get started in January 2019 after the November 2016 ballot initiative passed overwhelmingly.

Politico reported this announcement and we find it significant as it comes at a crucial time for the United States legal cannabis industry.

Becerra said, “I would love to see Jeff Sessions come to California and tell us we’re not going to move forward on cannabis. Something tells me, that it’s not going to happen. I’ll probably be the one millionth person in line to fight Jeff Sessions on that.”

United States has reached an Inflection Point

The United States cannabis industry is at a crossroads and it has moved too far forward to try to pull it back now. We do not expect the war on cannabis to continue much longer as it does not make economic sense.

29 states have legalized medical marijuana and eight states and the District of Columbia have legalized recreational marijuana. The legal cannabis industry is already a multi-billion-dollar industry and it is not even in the first inning of what will be one of the biggest growth cycles ever seen.

Momentum and support for cannabis, especially medical cannabis has never been higher. Earlier this year, a Quinnipiac poll reported that 71% of Americans would oppose a federal crackdown on legal cannabis and that 93% are in favor of medical cannabis.

The legal cannabis industry is the fastest growing industry in the world and it employs hundreds of thousands of people. If the government tried to shut the industry down, it would cost trillions of dollars and destroy new revitalized economies across the country.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Comments

Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link